...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis, biological activity, and mechanism of action of new 2-pyrimidinyl hydrazone and N-acylhydrazone derivatives, a potent and new classes of antileishmanial agents
【24h】

Synthesis, biological activity, and mechanism of action of new 2-pyrimidinyl hydrazone and N-acylhydrazone derivatives, a potent and new classes of antileishmanial agents

机译:新型2-嘧啶腙和N-酰腙衍生物,有效和新的抗体癌症药物的合成,生物活性和作用机理

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In this work, we report the antileishmanial activity of 15 compounds based on 2-pyrimidinyl hydrazone and N-acylhydrazone derivatives, being 13 new compounds. All compounds were tested against promastigotes and Leishmania amazonensis-GFP amastigotes, as well as murine macrophages. Besides, studies about the mechanism of action of the best antileishmanial compounds and in silico physicochemical and pharmacokinetic properties were performed. Studies about the mechanism of action of representative compounds of each class showed slight differences in mode of action and both are able to cause mitochondrial depolarization and increase of intracellular ROS levels. Through computational tool and further analysis of the physicochemical and pharmacokinetic parameters, the results indicating good oral bioavailability. These results confirm the potential of 2-pyrimidinyl derivatives as lead compounds in antileishmanial drug discovery. (C) 2019 Published by Elsevier Masson SAS.
机译:在这项工作中,我们报告了基于2-嘧啶基腙和N-酰腙衍生物的15种化合物的抗腹饲养活性,是13种新化合物。 所有化合物都针对Promastigotes和Leishmania Amazonensis-GFPAmastigotes以及鼠巨噬细胞进行了测试。 此外,进行了关于最佳抗碱基化合物和硅理物质化学和药代动力学性能的作用机制的研究。 关于每种阶级代表性化合物的作用机制的研究表明,动作模式和两者都能够引起线粒体去极化和细胞内ROS水平的增加。 通过计算工具和对物理化学和药代动力学参数的进一步分析,结果表明良好的口腔生物利用度。 这些结果证实了2-嘧啶基衍生物的潜力作为抗体鳞片药物发现中的铅化合物。 (c)2019年由Elsevier Masson SA发布。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号